> Skip repeated content


Long Interstimulus Interval Facilitation of Transcranial Motor Evoked Potentials

IRB Number: 11160
(inactive trial)

Institutional Review Board, Hospital for Special Surgery

November 22, 2011

The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.

Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.

For further information, see Understanding Clinical Trials.

Principal Investigator

Ronald G. Emerson, MD


Robert W. Kantor


Data from 20 patients

Inclusion/Exclusion Criteria

Patients have motor evoked potential monitoring within the  past eight months.

Contact Information

Ronald G. Emerson,MD